NYSE$EPC

Edgewell Personal Care · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Edgewell reported an increase in net sales and operating income for the fourth quarter and fiscal year 2021, and provided its financial outlook for fiscal year 2022.

Edgewell Personal Care announced strong Q4 and fiscal year 2021 results, with net sales increasing by 11.1% in Q4 and 7.1% for the full year. Organic net sales increased by 8.4% for the quarter and 3.7% for the full year. The company completed Project Fuel, achieving ~$280 million in cumulative gross savings, and initiated fiscal 2022 outlook for growth in organic net sales, adjusted EPS, and adjusted EBITDA. Additionally, the company announced its intent to repurchase approximately $300 million in common shares over the next three fiscal years.

  • Net sales increased 11.1% in the fourth quarter of fiscal 2021.
  • Organic net sales increased 8.4% for the quarter.
  • GAAP Diluted Earnings Per Share (EPS) were $0.80 for the fourth quarter.
  • Adjusted EPS were $1.01 for the fourth quarter.

Headline financials

Total Revenue

$543M

Previous: $489M+11.1%
EPS (adj)

$1.01

Previous: $0.59+71.2%
Gross Margin

45.1%

Previous: 45.4%-0.7%
Adjusted EBITDA

$102M

No prior period
Net Income

$44.1M

Previous: $21M+110.0%
Operating Income

$63.2M

Previous: $24.2M+161.2%
Gross Profit

$245M

Previous: $222M+10.2%
Cash & Equivalents

$479M

Previous: $365M+31.4%
Total Assets

$3.67B

Previous: $3.54B+3.8%
Stock-Based Comp

$7.7M

Previous: $4.1M+87.8%

Revenue & EPS history

Edgewell · Revenue · Quarterly

$543M

Q4 2021+11.1%vs Q4 2020
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Revenue by segment

Edgewell · $467M total across 2 segments · Q4 2021

  • Wet Shave
    $339M+3.8%
  • Sun and Skin Care
    $128M+37.9%

Forward guidance

The Company is providing the following outlook assumptions for fiscal 2022:

Tailwinds

  • Reported net sales to increase low-single digits
  • Includes: 110 basis-point negative impact from currency translation
  • Organic sales to increase low-single digits
  • GAAP EPS in the range of $2.73 to $3.01
  • Includes: Restructuring charges* of $17 million and Sun Care Monograph costs of approximately $2 million

Headwinds

  • Adjusted EPS in the range of $2.98 to $3.26
  • The EPS outlook includes an assumption that share repurchases will offset dilution only.
  • Adjusted EBITDA in the range of $365 to $385 million
  • Adjusted effective tax rate to be in the range of 22% to 23%
  • Capital expenditures approximately 3.0% of net sales

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+0.2%

Avg return

Earnings day

+0.1%

Avg return

5 days after

-0.8%

Avg return

30 days after

56%

38 / 68 earnings

Positive

+20.1%

Q1 2020

Best reaction

-17.0%

Q2 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026+2.2%-13.9%-13.1%
Q1 2026-4.6%+5.5%-4.0%
Q4 2025-2.7%-10.8%-8.0%
Q2 2025-10.2%-4.3%-9.9%
Q1 2025-9.5%-5.8%-2.5%
Q4 2024-0.5%-2.8%+1.1%
Q3 2024-0.2%-0.7%+5.8%
Q2 2024+4.4%+7.9%+3.4%
Q1 2024+5.6%+6.6%+2.8%
Q4 2023-2.5%+1.6%-0.7%
Q3 2023-2.8%-2.1%-2.1%
Q2 2023+1.9%+2.6%-2.0%
Q1 2023+4.7%+5.7%-3.8%
Q4 2022+0.9%+2.8%+3.5%
Q3 2022+2.6%+4.0%-3.9%
Q2 2022-11.8%-10.6%-8.8%
Q1 2022-11.0%-15.1%-17.0%
Q4 2021+13.9%+14.6%+17.2%
Q3 2021+8.0%+8.8%+0.6%
Q2 2021+9.1%+10.4%+13.2%
Q1 2021+0.6%-2.7%+1.5%
Q4 2020+9.2%+13.2%+12.1%
Q3 2020-7.8%-5.0%-1.0%
Q2 2020+11.1%+2.7%+22.6%
Q1 2020+20.1%+10.4%-2.1%
Q4 2019-11.4%-15.5%-13.2%
Q3 2019+7.5%+2.2%+2.8%
Q2 2019-17.0%-15.1%-22.8%
Q1 2019+6.6%+10.0%+9.1%
Q4 2018-9.6%-6.1%-11.6%
Q3 2018+2.8%+2.4%-1.3%
Q2 2018-1.4%+2.2%+5.1%
Q1 2018-4.5%-4.4%+0.8%
Q4 2017-6.5%-5.1%-2.8%
Q3 2017+2.5%+3.3%+2.2%
Q2 2017+5.4%+3.6%+3.5%
Q1 2017-1.4%-1.7%-2.4%
Q4 2016+8.2%+8.7%+1.7%
Q3 2016-5.4%-2.9%-5.9%
Q2 2016-3.7%
Q1 2016-0.2%
Q4 2015-3.0%
Q3 2015+0.4%
Q2 2015+0.9%
Q1 2015-1.6%
Q4 2014-0.0%
Q3 2014-0.3%
Q2 2014+3.6%
Q1 2014-0.6%
Q4 2013+1.4%
Q3 2013-2.5%
Q2 2013+3.8%
Q1 2013+2.8%
Q4 2012+0.0%
Q3 2012-13.5%
Q2 2012-2.2%
Q1 2012+2.3%
Q4 2011-1.7%
Q3 2011+1.0%
Q2 2011+0.5%
Q1 2010+0.3%
Q1 2011+0.1%
Q2 2010+1.5%
Q4 2008+1.5%
Q4 2010+1.5%
Q3 2009+4.3%
Q3 2010+4.3%
Q4 2009+4.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro